ZC3H12D and head and neck squamous cell carcinoma: Furthermore, expression and prognostic analyses of ZC3H12D indicated that ZC3H12D could serve as a potential diagnostic and prognostic biomarker for HNSCC, especially OSCC under the classification of HNSCC, and that increased expression of ZC3H12D was associated with better clinical outcomes.